Benign Prostatic Hyperplasia (BPH), commonly known as
enlarged prostate, is the silent disease among men. Afflicting
over 10 million American males, BPH is a painful and embarrassing
ailment. The disease begins with an increased need to urinate (often at
night), frequently coupled with difficulty in doing so. This leads to
general pain and discomfort in the groin region, a feeling of residual
urine in the bladder even after voiding and, in serious cases, may
result in the complete inability to urinate.
Why does this happen? Well, no one is exactly sure.
Located around the urethra at the point of the bladder, the prostate’s
main function is to help produce semen. As a man ages, the prostate
grows, eventually clamping down on the urethra and obstructing the flow
of urine from the bladder.
Mainline treatments range from medications (with
unpleasant and harmful side effects) to, in advanced cases, various
forms of surgery – which can result in permanent impotence. This
does not have to be so.
The Prostabrit solution
Used successfully for over 30 years in Europe and
Asia, Prostabrit is a combination of extracts from the pollen of eight
different plants: rye, maize, timothy, hazel, pine, oxeye daisy, sallow
and aspen. Discovered in Sweden almost half a century ago, this
non-allergenic mixture has proven remarkably effective in the treatment
of BPH.
In 1988, a double-blind, placebo-controlled study
concluded that Prostabrit improved nocturia (excessive urination at
night – the principle symptom of BPH) in 68.8% of the cases, as
opposed to 37.2% of the placebo group. In regard to residual urine
(urine that remains in the bladder), 54.7% of the Prostabrit group
showed improvement, as compared with only 12.5% of the placebo.
A second double-blind, placebo-controlled study,
published in 1990, mirrored these results. In it, Prostabrit was found
to either eliminate or improve nocturia in 60% of the BPH patients
tested. This compared with 30% of the subjects on the placebo. Even more
impressive was the improvement in bladder emptying - 57% of the
Prostabrit users vs. only 10% of the placebo group. All told, 60% of the
Prostabrit patients reported an overall improvement in their BPH
symptom, as compared with 29% in the placebo group.
Some naked truth from the nude mouse
Because of the strong placebo effect found in most
clinical trials of patients with BPH, researchers devised a study to
eliminate that bias. Human BPH tissue was transplanted onto 12 nude
mice. The mice were then separated into three groups: the first
remaining a control, the second receiving a silicon implant to stimulate
the BPH tissue, and the third receiving the implant and
Prostabrit. After six weeks, the tissue on the mice was examined, and
the results were dramatic.
While the BPH tissue if the second group (which
received the stimulation alone) grew, the tissue in the Prostabrit group
shrank – even
with the stimulation. The researchers concluded that Prostabrit
is the first plant-derived drug to show a significant growth-inhibiting
effect on human BPH tissue.
What does this mean for those who suffer from BPH?
Simply put, users of Prostabrit can benefit from its proven
ability to inhibit or reverse the growth of enlarged prostates.
"The Miracle of Prostabrit"
In 1998, Prostabrit received strong support from a
prominent Georgetown University doctor. In his book, The Prostate Cure: The
Revolutionary Natural Approach to Treating Enlarged Prostates, Harry
Preuss,M.D., urged the use of Prostabrit for BPH patients. Devoting an
entire chapter (titled, "The Miracle of Prostabrit") to the
product, Preuss underscored the proven clinical effectiveness of
the pollen extract, coupled with almost no side effects. Indeed, one
study concluded that Prostabrit’s tolerance was 99% among users (the
single reported side effect being rare upset stomach).
The researchers concluded that
Prostabrit
is the first plant-derived drug to show a significant
growth-inhibiting effect on human BPH tissue.
According to Preuss, scientists have established three
main beneficial components of Prostabrit’s activity: